PMS62 - Organizational and Management Impact Analysis of Using the New Subcutaneous Formulation of Tocilizumab in Selected Italian Rheumatology Centers
| Autor: | Ravera, S., Tomic, R., Adami, S., Viapiana, O., Paolini, D., Bianchino, L., Canciani, M., Farina, M., Ciancio, G., Govoni, M. |
|---|---|
| Zdroj: | In Value in Health November 2014 17(7):A383-A383 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect